Cardiolipin Antibody (IgG)

There are no preparation instructions.

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: Anti-Cardiolipin IgG, Cardiolipin Antibody IgG, Phospholipid Antibody, IgG

Cardiolipin Ab (IgG)

*Important Information on Lab Test Processing Times: Ulta Lab Tests is committed to informing you about the processing times for your lab tests processed through Quest Diagnostics. Please note that the estimated processing time for each test, indicated in business days, is based on data from the past 30 days across the 13 Quest Diagnostics laboratories for each test. These estimates are intended to serve as a guide and are not guarantees. Factors such as laboratory workload, weather conditions, holidays, and the need for additional testing or maintenance can influence actual processing times. We aim to offer estimates to help you plan accordingly. Please understand that these times may vary, and processing times are not guaranteed. Thank you for choosing Ulta Lab Tests for your laboratory needs.

The Cardiolipin Antibody (IgG) test contains 1 test with 1 biomarker.

Brief Description: The Cardiolipin IgG Antibody test is a blood test specifically designed to detect antibodies against cardiolipin in the IgG form. Cardiolipin is a phospholipid found in the inner mitochondrial membrane of cells. The body can produce antibodies against cardiolipin, and their presence can indicate specific autoimmune conditions.

Collection Method: Blood Draw

Specimen Type: Plasma

Test Preparation: No preparation required

When and Why a Cardiolipin IgG Antibody Test May Be Ordered

A healthcare provider may order the Cardiolipin IgG Antibody test under the following circumstances:

  1. Suspicion of Antiphospholipid Syndrome (APS): If a patient has experienced unexplained blood clots in veins or arteries, repeated miscarriages, or prolonged clotting times in other blood tests.
  2. Systemic Lupus Erythematosus (SLE) Monitoring: While not all SLE patients have antiphospholipid antibodies, their presence can indicate a higher risk for clotting events in these individuals.
  3. Unexplained Prolonged PTT: PTT (partial thromboplastin time) is a test that measures how long it takes blood to clot. If the PTT is prolonged without a known reason, a Cardiolipin IgG Antibody test might be ordered.

What the Cardiolipin IgG Antibody Test Checks For

This test detects the presence and measures the levels of IgG antibodies produced against cardiolipin. The presence of these antibodies can suggest an increased risk of blood clots, miscarriages, and other symptoms related to conditions like APS.

Additional Lab Tests Ordered Alongside the Cardiolipin IgG Antibody Test

When a Cardiolipin IgG Antibody test is ordered, it's often part of a broader evaluation of clotting disorders and autoimmune conditions. Here are some tests commonly ordered alongside it:

  1. Cardiolipin IgM and IgA Antibodies:

    • Purpose: To measure IgM and IgA antibodies against cardiolipin.
    • Why Is It Ordered: To provide a comprehensive assessment for antiphospholipid syndrome, as different isotypes of cardiolipin antibodies can be relevant.

  2. Beta-2 Glycoprotein 1 Antibodies (IgG, IgM, IgA):

    • Purpose: To detect antibodies against beta-2 glycoprotein 1, another target in antiphospholipid syndrome.
    • Why Is It Ordered: To support the diagnosis of APS, as these antibodies are also considered diagnostic criteria.

  3. Lupus Anticoagulant Testing:

    • Purpose: To detect the presence of lupus anticoagulants, which are antibodies associated with an increased risk of clotting.
    • Why Is It Ordered: To further evaluate for APS and to assess the risk of clotting, especially in patients with a history of thrombosis or recurrent miscarriage.

  4. Complete Blood Count (CBC):

    • Purpose: To evaluate overall blood health, including red and white blood cells, and platelets.
    • Why Is It Ordered: To identify any blood cell abnormalities that can occur with APS or associated autoimmune disorders.

  5. Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT):

    • Purpose: To assess the blood's clotting ability.
    • Why Is It Ordered: To evaluate the clotting system, which can be affected in APS. Lupus anticoagulant can prolong aPTT.

  6. ANA (Antinuclear Antibody) Test:

    • Purpose: To screen for autoantibodies often present in autoimmune diseases.
    • Why Is It Ordered: To assess for systemic autoimmune disorders like lupus, which can be associated with APS.

  7. Kidney Function Test:

    • Purpose: To assess kidney function.
    • Why Is It Ordered: Because APS can affect kidney function, and kidney health is crucial in the context of autoimmune diseases.

These tests, when ordered alongside a Cardiolipin IgG Antibody test, provide a comprehensive evaluation for antiphospholipid syndrome and related conditions. They are crucial for diagnosing APS, assessing the risk of clotting complications, and identifying associated autoimmune disorders. The specific combination of tests will depend on the individual's symptoms, clinical history, and risk factors for thrombosis.

Conditions or Diseases Requiring a Cardiolipin IgG Antibody Test

The primary condition associated with the presence of cardiolipin antibodies is Antiphospholipid Syndrome (APS). This autoimmune disorder increases the risk of blood clots in arteries and veins. APS can also be associated with Systemic Lupus Erythematosus (SLE), another autoimmune disorder, although not all lupus patients will have APS.

Usage of Cardiolipin IgG Antibody Test Results by Health Care Providers

The presence of cardiolipin antibodies, particularly in high amounts, supports a diagnosis of APS, especially when the patient has a history of clotting events or recurrent miscarriages. However, the test must be interpreted in the context of the patient's clinical history and other lab results. A positive test doesn't necessarily confirm APS, and a negative test doesn't rule it out. If a patient is diagnosed with APS based on the test results and clinical signs, they might be prescribed anticoagulant medications to reduce the risk of blood clots. Regular monitoring and follow-up tests will often be required.

Most Common Questions About the Cardiolipin Antibody (IgG) test:

Understanding the Basics

What is the purpose of the Cardiolipin IgG Antibody test?

The Cardiolipin IgG Antibody test is primarily used to help determine if a person has antiphospholipid syndrome (APS), an autoimmune disorder that increases the risk of blood clots. The test detects the presence of IgG antibodies against cardiolipin, a type of fat molecule found in the outermost layer of cells and blood platelets.

How do Cardiolipin IgG Antibodies relate to autoimmune disorders?

Cardiolipin IgG antibodies are a type of antiphospholipid antibody. In individuals with certain autoimmune disorders, the immune system mistakenly targets and attacks phospholipids, including cardiolipin. The presence of these antibodies can result in increased blood clotting, leading to conditions like deep vein thrombosis, pulmonary embolism, or recurrent miscarriages in women.

Medical Implications and Applications

Why is the Cardiolipin IgG Antibody test recommended for individuals with recurrent miscarriages or blood clotting disorders?

For individuals who have experienced recurrent miscarriages or have a history of unexplained blood clotting disorders, the Cardiolipin IgG Antibody test can help identify the presence of antiphospholipid antibodies, which may be contributing to these issues. Detecting and managing antiphospholipid syndrome early can be crucial in preventing complications and providing appropriate treatment options.

Besides antiphospholipid syndrome, are there other conditions where the Cardiolipin IgG Antibody test might be used?

Yes, the Cardiolipin IgG Antibody test might also be recommended for individuals with systemic lupus erythematosus (SLE) or other autoimmune disorders, as these conditions can be associated with higher levels of antiphospholipid antibodies. Moreover, the test can aid in determining the cause of unexplained strokes or other vascular diseases in younger individuals.

General Knowledge and Considerations

How does the Cardiolipin IgG Antibody test differ from other antiphospholipid antibody tests?

The Cardiolipin IgG Antibody test specifically measures the IgG antibodies against cardiolipin. There are other antiphospholipid antibody tests that measure different antibodies, like the Cardiolipin IgM or IgA antibody tests, or the lupus anticoagulant test. Each test provides unique information, and the type of test ordered depends on the specific clinical scenario and what the healthcare provider is trying to determine.

What can cause false positives in the Cardiolipin IgG Antibody test?

Certain infections, like syphilis, can lead to false-positive results in the Cardiolipin IgG Antibody test. Additionally, certain medications, older age, and other autoimmune diseases can also result in false-positive results. It's essential for clinicians to interpret the test results in the context of the patient's overall clinical picture.

Test Interpretation

What do normal and abnormal results from the Cardiolipin IgG Antibody test indicate?

Normal results, which show no significant levels of Cardiolipin IgG antibodies, suggest that the individual is not likely to have antiphospholipid syndrome or other associated conditions. Abnormal or positive results indicate elevated levels of Cardiolipin IgG antibodies, which can be associated with an increased risk of blood clots, recurrent miscarriages, or other complications. However, one positive test does not confirm a diagnosis; typically, repeated testing and clinical evaluation are necessary to establish a definitive diagnosis.

We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.

Customer Reviews